FutureChem Co.,Ltd
KOE: 220100.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Dae-Yoon Chi
- Employees
- 66
- Headquarters
- Seoul, South Korea
- IPO year
- 2016
- Market cap
- ₩407.9B
- Website
- https://www.futurechem.co.kr
Loading 220100…
Loading profile data…Frequently asked questions about 220100
What does FutureChem Co.,Ltd (220100.KQ) do?
FutureChem Co.,Ltd produces and sells radiopharmaceuticals in Korea. The company offers PDVUE, a positron emission tomography (PET) radiopharmaceutical diagnostic medicine for Parkinson's disease; Alzavue, a diagnostic medicine for Aalzheimer's disease; and [18F]FDG, a PET radiopharmaceutical for the treatment of cancer. Its products in pipeline...
Where does 220100.KQ trade?
FutureChem Co.,Ltd (220100.KQ) trades on the KOSDAQ.
What sector is 220100.KQ in?
FutureChem Co.,Ltd (220100.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of FutureChem Co.,Ltd?
Dae-Yoon Chi is the chief executive officer of FutureChem Co.,Ltd (220100.KQ).
Where is FutureChem Co.,Ltd headquartered?
FutureChem Co.,Ltd is headquartered in South Korea.
Does 220100.KQ pay a dividend?
FutureChem Co.,Ltd (220100.KQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 220100.KQ go public?
FutureChem Co.,Ltd (220100.KQ) completed its initial public offering in 2016.